Ironwood Pharma (IRWD) Posts Q2 Loss of 57c/Share; Affirms Outlook

July 23, 2013 8:28 AM

Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.57), $0.11 better than the analyst estimate of ($0.68). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found